{
    "study_accession": "SDY903",
    "actual_completion_date": "2017-01-02",
    "actual_enrollment": 29,
    "actual_start_date": "2016-10-01",
    "age_unit": "Years",
    "brief_description": "T cell human Immune Signature of Zika infection was studied",
    "brief_title": "Human Immune Signature of Zika virus infection",
    "clinical_trial": "N",
    "condition_studied": "Zika virus infection",
    "dcl_id": 2,
    "description": "The human Immune Signature of Zika virus infection was studied in a Zika endemic area, Brazil. T cell responses were compared in acute infected patients as well as convalescent patients.",
    "doi": "10.21430/M340DHRY4Y",
    "endpoints": "Compare T cell response of acute and convalescent Zika virus infected patients by flow cytometry and RNA sequencing",
    "gender_included": "Not Specified",
    "hypothesis": "Compare T cell response of acute versus convalescent Zika virus infected patients",
    "initial_data_release_date": "2019-01-16",
    "initial_data_release_version": "DR29",
    "intervention_agent": "Zika",
    "latest_data_release_date": "2019-01-16",
    "latest_data_release_version": "DR29",
    "maximum_age": "  17.00",
    "minimum_age": "  17.00",
    "objectives": "To determine the T cell immune signature of Zika virus infection",
    "official_title": "Phenotyping and mRNA profiling of Zika virus-specific CD4 and CD8 T cells",
    "sponsoring_organization": "NIAID",
    "target_enrollment": 30,
    "workspace_id": 4876,
    "research_focus": [
        "Infection Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM3367",
            "description": "Patients with an acute Zika virus infection living in a Zika endemic area such as Brazil",
            "name": "Acute Zika virus infected patients"
        },
        {
            "arm_accession": "ARM3368",
            "description": "Patients who had an acute Zika virus infection and are now at least 2 weeks post-infection that were infected in an endemic area",
            "name": "Convalescent Zika virus infected patients"
        },
        {
            "arm_accession": "ARM3369",
            "description": "Individuals from a Zika endemic areas, such as Brazil, who have not been infected with Zika virus",
            "name": "Non-Zika virus infected individuals from a Zika endemic area"
        }
    ],
    "personnel": [
        {
            "first_name": "Daniela",
            "last_name": "Weiskopf",
            "organization": "La Jolla Institute for Allergy and Immunology",
            "role_in_study": "Principal Investigator",
            "site_name": "La Jolla Institute for Allergy and Immunology"
        }
    ],
    "pubmed": [],
    "program": [
        {
            "program_name": "Human Immunology Project Consortium (HIPC) RFA-AI-15-041",
            "contract_name": "Human immune signatures of dengue virus and mycobacterium tuberculosis exposure in infection; disease and vaccination (La Jolla)"
        }
    ],
    "assay": [
        {
            "measurement_technique": "Flow Cytometry",
            "number_of_expsamples": 72
        },
        {
            "measurement_technique": "HLA Typing",
            "number_of_expsamples": 29
        },
        {
            "measurement_technique": "RNA sequencing",
            "number_of_expsamples": 60
        }
    ],
    "subject": {
        "race": [
            {
                "race": "American Indian or Alaska Native",
                "count": 1
            },
            {
                "race": "Unknown",
                "count": 28
            }
        ],
        "gender": [
            {
                "Female": 6
            },
            {
                "Male": 8
            },
            {
                "Unknown": 15
            }
        ]
    }
}
